1. Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review

   • Hans-Jürgen Möller
   • Peter Falkai

   Editorial Open access 15 February 2023 Pages: 1 - 3

2. Association between the HTR1A rs6295 gene polymorphism and suicidal behavior: an updated meta-analysis

   • Yazmin Hernández-Díaz
   • Carlos Alfonso Tovilla-Zárate
   • Thelma Beatriz González-Castro

   Original Paper 10 October 2022 Pages: 5 - 14

   

3. Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD

   • Gabriela Pessin Meyer
   • Bruna Santos da Silva
   • Claiton Henrique Dotto Bau

   Original Paper 12 March 2022 Pages: 15 - 24

4. Working memory dysfunction in fibromyalgia is associated with genotypes of the catechol- O-methyltransferase gene: an event-related potential study

   • David Ferrera
   • Francisco Gómez-Esquer
   • Francisco Mercado

   Original Paper Open access 13 September 2022 Pages: 25 - 40

   

5. Temperament traits mediate the relationship between CACNA1C polymorphisms and bipolar disorder in cisgender women

   • Clarissa Ribeiro Bastos
   • Bertha Bueno Bock
   • Gabriele Ghisleni

   Original Paper 01 October 2022 Pages: 41 - 50

   

6. Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited

   • Lucie Bartova
   • Markus Dold
   • Siegfried Kasper

   Original Paper Open access 09 March 2022 Pages: 51 - 63

   

7. Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data

   • Mateo de Bardeci
   • Waldemar Greil
   • Johanna Seifert

   Original Paper Open access 25 February 2022 Pages: 65 - 74

   

8. Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder

   • X. M. Hart
   • S. Heesen
   • U. Havemann-Reinecke

   Original Paper Open access 07 October 2022 Pages: 75 - 83

   

9. Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocol

   • Esther Dechantsreiter
   • Frank Padberg
   • Mor Nahum

   Original Paper Open access 22 October 2022 Pages: 85 - 98

   

10. Genetic profile for dopamine signaling predicts brain functional reactivity to repetitive transcranial magnetic stimulation

    • Haejin Hong
    • Rye Young Kim
    • Suji Lee

    Original Paper 11 August 2022 Pages: 99 - 111

    

11. Predicting treatment outcome in depression: an introduction into current concepts and challenges

    • Nicolas Rost
    • Elisabeth B. Binder
    • Tanja M. Brückl

    Original Paper Open access 19 May 2022 Pages: 113 - 127

    

12. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials

    • Giordano Novak Rossi
    • Jaime E. C. Hallak
    • Rafael G. dos Santos

    Invited Review 13 July 2022 Pages: 129 - 155

    

13. Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis

    • Irina S. Boksha
    • Maria A. Omel’chenko
    • Gulnur Sh. Burbaeva

    Original Paper 15 March 2022 Pages: 157 - 168

    

14. Aberrant temporal–spatial complexity of intrinsic fluctuations in major depression

    • Kaizhong Zheng
    • Baojuan Li
    • Lingjiang Li

    Original Paper 13 April 2022 Pages: 169 - 181

    

15. Association of high BMI with subclinical hypothyroidism in young, first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study

    • Chuanyi Kang
    • Jiacheng Liu
    • Xiangyang Zhang

    Original Paper 12 May 2022 Pages: 183 - 190

16. Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder

    • Wanqiu Yang
    • Miao Qu
    • Xiang-Yang Zhang

    Original Paper 18 July 2022 Pages: 191 - 198

17. Metabolic parameters and thyroid hormones in relation to suicide attempts in patients with first-episode and drug-naive major depressive disorder with comorbid glucose disturbances: a large cross-sectional study

    • Shi wang Chen
    • Xue Li
    • Xiang-yang Zhang

    Original Paper 20 September 2022 Pages: 199 - 207

18. No effects of acute tryptophan depletion on anxiety or mood in weight-recovered female patients with anorexia nervosa

    • Tomas Weinert
    • Fabio Bernardoni
    • Stefan Ehrlich

    Original Paper Open access 05 May 2022 Pages: 209 - 217

19. Dementia risk in middle-aged patients with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of 84,824 subjects

    • Ying-Jay Liou
    • Shih-Jen Tsai
    • Mu-Hong Chen

    Original Paper 26 April 2022 Pages: 219 - 227

    

20. Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer’s disease

    • Riccardo Manca
    • Jose Manuel Valera-Bermejo
    • for the Alzheimer’s Disease Neuroimaging Initiative

    Original Paper Open access 13 May 2022 Pages: 229 - 241

    

21. Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis

    • Jose Contador
    • Ana Magdalena Vargas-Martínez
    • Albert Lladó

    Original Paper 16 June 2022 Pages: 243 - 252

    

22. The neural signatures of psychoses in Alzheimer’s disease: a neuroimaging genetics approach

    • Riccardo Manca
    • Antonio F. Pardiñas
    • for the Alzheimer’s Disease Neuroimaging Initiative

    Original Paper Open access 21 June 2022 Pages: 253 - 267

    

23. Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice

    • Martina Stazi
    • Silvia Zampar
    • Oliver Wirths

    Original Paper Open access 09 June 2022 Pages: 269 - 281

    

24. Canonical insulin signaling is not significantly impaired in early stages of depression

    • Deepti Singh
    • Henrik Dobrowolny
    • Johann Steiner

    Short Communication 07 May 2022 Pages: 283 - 286